Well I was wrong, it was not with Pestell, it seemed like he was talking about Gilead or something. The audio was pretty hard to hear.

So some points..

2 or 3 pharmaceutical companies looking to advance fund.

Dr. Pestell prostate test close to license deal

Gilead said they are weary of investing because it is a new type of medicine, one that is not the standard.

Valuation of the company with monotherapy alone could be in the double digit stock price.

Dr. Pestell said the company is near its inflection point.

NP laughed when he said the company's share price is .40 cents. Saying it was ridiculously below ROI.

FDA called yesterday and said they would work with them on the pivotal study standard. They will work together at the 525mg point since efficacy is 95%. Details coming soon.

SAMSUNG has discussed injecting the company with advanced funds. Samsung wants them to succeed and willing to help in any way.

The board and NP are in ageeeance that the stock should raise organically.

So many talking points and really getting excited.